We are live on ! Find out more
MCM

McRae Capital Management Portfolio holdings

AUM $508M
1-Year Est. Return 14.21%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+14.21%
3 Year Est. Return
+59.23%
5 Year Est. Return
+71.2%
10 Year Est. Return
+359.88%
AUM
$271M
AUM Growth
+$14.9M
Cap. Flow
-$3.08M
Cap. Flow %
-1.13%
Top 10 Hldgs %
42.44%
Holding
101
New
10
Increased
26
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.41M
2
CRNC icon
Cerence
CRNC
+$894K
3
KEYS icon
Keysight
KEYS
+$734K
4
OMC icon
Omnicom Group
OMC
+$427K
5
KMI icon
Kinder Morgan
KMI
+$423K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$10.1M
2
TPR icon
Tapestry
TPR
+$3.33M
3
XOM icon
ExxonMobil
XOM
+$291K
4
MMM icon
3M
MMM
+$230K
5
ADP icon
Automatic Data Processing
ADP
+$199K

Sector Composition

Rank Sector Weight
1 Technology 28.26%
2 Healthcare 17.57%
3 Financials 17.49%
4 Consumer Discretionary 15.03%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IJR icon
51
iShares Core S&P Small-Cap ETF
IJR
$109B
$622K 0.23%
7,421
+353
+5% +$28.4K
PFE icon
52
Pfizer
PFE
$143B
$622K 0.23%
16,743
– –
MRK icon
53
Merck
MRK
$322B
$617K 0.23%
7,114
-205
-3% -$16.8K
VZ icon
54
Verizon
VZ
$197B
$613K 0.23%
9,988
+1,188
+14% +$71.7K
NVT icon
55
nVent Electric
NVT
$21.6B
$595K 0.22%
23,248
-2,987
-11% -$69.4K
IJH icon
56
iShares Core S&P Mid-Cap ETF
IJH
$121B
$565K 0.21%
13,725
+755
+6% +$29.9K
AMGN icon
57
Amgen
AMGN
$209B
$539K 0.2%
2,236
+750
+50% +$165K
HON icon
58
Honeywell
HON
$76.4B
$514K 0.19%
3,081
+1
+0% +$163
AEM icon
59
Agnico Eagle Mines
AEM
$72.2B
$493K 0.18%
8,000
– –
HD icon
60
Home Depot
HD
$337B
$471K 0.17%
2,155
– –
AIG icon
61
American International
AIG
$42.5B
$468K 0.17%
9,125
– –
COP icon
62
ConocoPhillips
COP
$144B
$463K 0.17%
7,123
-402
-5% -$23.6K
FTV icon
63
Fortive
FTV
$18B
$457K 0.17%
9,494
– –
DIS icon
64
Walt Disney
DIS
$171B
$440K 0.16%
3,045
– –
COST icon
65
Costco
COST
$432B
$431K 0.16%
1,467
– –
SPY icon
66
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$425K 0.16%
1,320
– –
XYL icon
67
Xylem
XYL
$28.5B
$395K 0.15%
5,017
+5
+0.1% +$389
CVX icon
68
Chevron
CVX
$382B
$369K 0.14%
3,066
-294
-9% -$34.6K
HPI
69
John Hancock Preferred Income Fund
HPI
$428M
$368K 0.14%
16,120
– –
MSGS icon
70
Madison Square Garden
MSGS
$9.59B
$360K 0.13%
+1,717
New +$337K
DD icon
71
DuPont de Nemours
DD
$18.6B
$345K 0.13%
4,286
-93
-2% -$7.72K
WFC icon
72
Wells Fargo
WFC
$254B
$337K 0.12%
6,272
– –
BMY.RT
73
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$304K 0.11%
+101,117
New +$263K
PEG icon
74
Public Service Enterprise Group
PEG
$38.7B
$300K 0.11%
5,075
– –
UNH icon
75
UnitedHealth
UNH
$382B
$294K 0.11%
1,000
-600
-38% -$157K
1 2
3
4 5

Similar funds

MCM
Maltese Capital Management New York $508M AUM 21.31% 1-Year Est. Return
MC
Machina Capital Paris, France $508M AUM 9.91% 1-Year Est. Return
OA
Oasis Advisors Forest City, Iowa $509M AUM
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
WMG
WESCAP Management Group Glendale, California $508M AUM 18.98% 1-Year Est. Return
PWMG
Prestige Wealth Management Group Flemington, New Jersey $509M AUM 15.69% 1-Year Est. Return
RFG
REAP Financial Group Austin, Texas $507M AUM 18.73% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

McRae Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, McRae Capital Management held 101 positions worth $271M, up 5.8% from $257M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

McRae Capital Management's Q4 2019 filing shows 10 new, 26 increased, 33 reduced and 3 closed positions. Its largest new stake was Cerence: 54,517 shares worth $1.23M. The largest sale was Celgene Corp, an estimated $10.1M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • McRae Capital Management's largest Q4 2019 buy was Cerence: 54,517 shares worth $1.23M.
  • McRae Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $6.41M increase.
  • McRae Capital Management's biggest Q4 2019 reduction was ExxonMobil, cutting an estimated $291K.
  • McRae Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $10.1M.
  • McRae Capital Management's ten largest holdings make up 42% of its $271M portfolio in Q4 2019.
  • McRae Capital Management opened 10 new positions and closed 3 in Q4 2019.
  • McRae Capital Management's portfolio value rose 5.8% quarter-over-quarter to $271M.

Based on McRae Capital Management's 13F filing for Q4 2019, filed 17 Jan 2020.